ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1367

Fibroblast-like Synoviocytes Shape and Perpetuate the Inflammatory Immune Responses Associated with Antibiotic-Refractory Lyme Arthritis.

Klemen Strle1, Robert Locchead2, Annalisa Pianta3, Jameson T. Crowley3, Sheila Arvikar1 and John Aversa4, 1Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Allery and Immunology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, 3Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Yale Medical Group, Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: cytokines, Fibroblasts, inflammation and polymorphism, Lyme disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Innate Immunity and Rheumatic Disease Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Antibiotic-refractory Lyme arthritis is defined as persistent synovitis for months to years after antibiotic therapy for Borrelia burgdorferi, the causative agent of Lyme disease. Rather than persistent infection, this condition is thought to result from inappropriate activation of inflammatory immune responses which are elicited by the spirochetes and further augmented by host genetics. Fibroblast-like synoviocytes (FLS) are the predominant cell type in hypertrophied synovial tissue, but their responses to B. burgdorferi are not well-defined. Here we assessed the inflammatory responses of FLS to a highly virulent B. burgdorferiRST1 strain and evaluated these responses according to a host TLR1-1805GG polymorphism, a risk factor for antibiotic-refractory Lyme arthritis.

Methods:

FLS were obtained from synovia of antibiotic-refractory Lyme arthritis patients who underwent synovectomies due to incomplete responses to treatment with antibiotics and then DMARDs. Protein levels of 8 matrix metalloproteinases and 21 cytokines and chemokines in B. burgdorferi-stimulated FLS were assessed using Luminex. mRNA expression in synovial biopsies and FLS was assessed using QuantiGene and whole-genome RNASeq analyses.

Results:

FLS sense and respond to B. burgdorferi by producing high levels of matrix metalloproteinases (MMP1, MMP2, MMP3, MMP9, and MMP13) which degrade cartilage and bone. In addition, B. burgdorferi-stimulated FLS produce large amounts of inflammatory mediators associated with both innate (IL-6, IL-8, IL-10, TNF, CCL2), and adaptive Th1-like responses (CXCL9, CXCL10). These responses corroborate in vivo findings in the joint fluid of patients with antibiotic-refractory Lyme arthritis, linking FLS to excessive joint inflammation. Moreover, FLS responded directly to stimulation with IFNγ, the prototypical Th1 effector cytokine, leading to high levels of CXCL9 and CXCL10, which are potent chemoattractants for CD4+Th1 cells, the predominant T-effector cell type in joints of patients with refractory arthritis. These responses were amplified in FLS from patients with a TLR1-1805GG polymorphism, which leads to diminished TLR1 expression on the cell surface. Cells with 1805GG had altered SOCS3 mRNA expression suggesting that the greater inflammatory responses in the 1805GG group may be due to a loss of a regulatory pathway. In addition, RNASeq analysis revealed that a deficiency in TLR1 in patients with 1805GG also leads to increased expression of other pathogen-recognition receptors, including TLRs and NODs, which could further contribute to excessive inflammation in patients with 1805GG.

Conclusion:

FLS are an important cell type in the pathogenesis of antibiotic-refractory Lyme arthritis because of their ability to shape and perpetuate innate and adaptive immune responses. These responses are altered in patients with TLR1-1805GG polymorphism, a risk factor for antibiotic-refractory Lyme arthritis.


Disclosure: K. Strle, NIH K (K01AR062098), 2,Arthritis Foundation, 2; R. Locchead, NIH NIAMS T32 AR007258-36a1, 2; A. Pianta, NIH NIAID (R01 A1-110175), 2; J. T. Crowley, NIH NIAID (R01 A1-110175), 2; S. Arvikar, None; J. Aversa, None.

To cite this abstract in AMA style:

Strle K, Locchead R, Pianta A, Crowley JT, Arvikar S, Aversa J. Fibroblast-like Synoviocytes Shape and Perpetuate the Inflammatory Immune Responses Associated with Antibiotic-Refractory Lyme Arthritis. [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fibroblast-like-synoviocytes-shape-and-perpetuate-the-inflammatory-immune-responses-associated-with-antibiotic-refractory-lyme-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibroblast-like-synoviocytes-shape-and-perpetuate-the-inflammatory-immune-responses-associated-with-antibiotic-refractory-lyme-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology